DK3199178T3 - Levende, svækket parvovirus - Google Patents

Levende, svækket parvovirus Download PDF

Info

Publication number
DK3199178T3
DK3199178T3 DK17156212.7T DK17156212T DK3199178T3 DK 3199178 T3 DK3199178 T3 DK 3199178T3 DK 17156212 T DK17156212 T DK 17156212T DK 3199178 T3 DK3199178 T3 DK 3199178T3
Authority
DK
Denmark
Prior art keywords
parvovirus
weakness
living
weakness parvovirus
Prior art date
Application number
DK17156212.7T
Other languages
English (en)
Inventor
Norman Spibey
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of DK3199178T3 publication Critical patent/DK3199178T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/23Parvoviridae, e.g. feline panleukopenia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14341Use of virus, viral particle or viral elements as a vector
    • C12N2750/14343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14361Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK17156212.7T 2010-07-16 2011-07-18 Levende, svækket parvovirus DK3199178T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10169872 2010-07-16
US36568410P 2010-07-19 2010-07-19
EP11732480.6A EP2593136B1 (en) 2010-07-16 2011-07-18 Live attenuated parvovirus

Publications (1)

Publication Number Publication Date
DK3199178T3 true DK3199178T3 (da) 2020-04-14

Family

ID=42629432

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11732480.6T DK2593136T3 (da) 2010-07-16 2011-07-18 Levende, svækket parvovirus
DK17156212.7T DK3199178T3 (da) 2010-07-16 2011-07-18 Levende, svækket parvovirus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11732480.6T DK2593136T3 (da) 2010-07-16 2011-07-18 Levende, svækket parvovirus

Country Status (12)

Country Link
US (1) US9186398B2 (da)
EP (2) EP2593136B1 (da)
JP (2) JP6061850B2 (da)
CN (2) CN107254451B (da)
BR (2) BR112012030659B8 (da)
CA (1) CA2802283C (da)
DK (2) DK2593136T3 (da)
ES (1) ES2623149T3 (da)
FR (1) FR21C1022I2 (da)
NL (1) NL301108I2 (da)
PT (1) PT2593136T (da)
WO (1) WO2012007589A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2593136T3 (da) * 2010-07-16 2017-05-08 Intervet Int Bv Levende, svækket parvovirus
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CN104812893B (zh) * 2012-11-22 2018-08-03 旭化成医疗株式会社 高感染滴度的细小病毒的生产方法
WO2014095956A1 (en) * 2012-12-19 2014-06-26 Intervet International B.V. CANINE PARVOVIRUS TYPE 2c ISOLATES AND METHODS OF USE
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
JP6414409B2 (ja) * 2014-07-29 2018-10-31 株式会社微生物化学研究所 弱毒化パルボウイルスおよび弱毒化パルボウイルスを用いたワクチン
CN109735505A (zh) * 2018-12-26 2019-05-10 河南农业大学 一株犬细小病毒毒株及其基因序列的扩增和应用
CN110845582B (zh) * 2019-12-23 2021-07-23 杭州贤至生物科技有限公司 一种猫细小病毒重组蛋白及其单克隆抗体的制备
CN116390753A (zh) 2020-11-04 2023-07-04 英特维特国际股份有限公司 犬细小病毒
CN114426956B (zh) * 2022-02-08 2023-11-17 辽宁益康生物股份有限公司 猫狂犬病泛白细胞减少症鼻气管炎鼻结膜炎四联灭活疫苗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
WO2008145400A2 (en) * 2007-05-31 2008-12-04 Medigene Ag Mutated structural protein of a parvovirus
EP2012122A1 (en) * 2007-07-06 2009-01-07 Medigene AG Mutated parvovirus structural proteins as vaccines
RU2519210C2 (ru) 2007-06-14 2014-06-10 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Вакцины, содержащие генетические варианты парвовируса собак
DK2593136T3 (da) * 2010-07-16 2017-05-08 Intervet Int Bv Levende, svækket parvovirus

Also Published As

Publication number Publication date
EP2593136B1 (en) 2017-03-08
US20130195913A1 (en) 2013-08-01
JP6061850B2 (ja) 2017-01-25
FR21C1022I1 (fr) 2021-07-16
PT2593136T (pt) 2017-05-03
ES2623149T3 (es) 2017-07-10
BR112012030659B8 (pt) 2022-10-04
EP3199178B1 (en) 2020-02-19
BR112012030659B1 (pt) 2021-12-21
CN102985108A (zh) 2013-03-20
FR21C1022I2 (fr) 2024-03-29
CN107254451A (zh) 2017-10-17
JP2017029140A (ja) 2017-02-09
DK2593136T3 (da) 2017-05-08
EP2593136A1 (en) 2013-05-22
CN107254451B (zh) 2021-12-10
CA2802283C (en) 2018-06-05
BR112012030659A8 (pt) 2021-09-28
EP3199178A1 (en) 2017-08-02
JP2013535188A (ja) 2013-09-12
JP6298499B2 (ja) 2018-03-20
BR122021023230B1 (pt) 2023-01-17
WO2012007589A1 (en) 2012-01-19
CA2802283A1 (en) 2012-01-19
BR122021023230B8 (pt) 2023-12-12
US9186398B2 (en) 2015-11-17
NL301108I2 (nl) 2024-01-29
BR112012030659A2 (pt) 2017-01-24

Similar Documents

Publication Publication Date Title
DK2591099T3 (da) Kimære koagulationsfaktorer
BR112012028556A2 (pt) Indóis
CR20130111A (es) Triazina-oxidiazoles
DE102011100241A8 (de) Nitridhalbleiterbauteil
DK3225404T3 (da) Fluidpatron
DE10170954T8 (de) Mikrowellendruckgarer
BR112012028549A2 (pt) escova de dentes
DE112011104226A5 (de) Käfigmutter
BR112013011850A2 (pt) escova de dentes
DK3199178T3 (da) Levende, svækket parvovirus
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
DE112011102080A5 (de) Kupplungszentralausrücker
DE112011101226A5 (de) Linearwegmesssystem
DK2442899T3 (da) Rotorskive
DK2539163T3 (da) Dækventil
DE102011002623A8 (de) Ventilsteuerzeitversteller
DE112011101333A5 (de) Parkouraufbau
DE112011102711A5 (de) Hydrostataktor
DK2448659T3 (da) Rotorskive
DK2447426T3 (da) Vaske-WC
BR112013014772A2 (pt) desodorizante
DE102010019119B8 (de) Cuttermesser
DE112010005518A5 (de) Dichtungsmanchette
DE102010038420A8 (de) Reinigungungsvorrichtung
DK2590565T3 (da) Blodprøvetagning